ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2026
Macrophages with ITIH4 overexpression attenuate inflammatory responses and regulate intestinal epithelial cells.
Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveInter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) is an acute phage protein and secretory protein that is highly related to inflammation. However, the expression profile and function of ITIH4 in macrophage-mediated inflammation are still unclear.
methodsQuantitative proteomics based on mass spectrometry was performed to explore differential protein expression in bone marrow-derived macrophages (BMDMs) subjected to the indicated treatments. Western blot and qRT-PCR assays were performed to confirm the expression of ITIH4 in macrophages. ITIH4 was overexpressed and knocked down in Raw264.7 cells, and ITIH4 was knocked down in THP-1 cells, after which the function and molecular mechanism of ITIH4 in macrophages were investigated. Immunohistochemical staining and online bioinformatics tools were used to explore the expression of ITIH4 in the inflamed colon. In addition, CCK8, scratch wound healing, RNA-seq, qRT-PCR and Western blot assays were performed to explore the function and mechanism of macrophages with ITIH4 overexpression in colonic epithelial cells.
resultsOur findings demonstrated that the expression of full-length ITIH4 increased in pro-inflammatory macrophages resulting from a decrease in cleavage, whereas treatment with 4-octyl itaconate (OI) promoted the synthesis and secretion of full-length ITIH4. We overexpressed or knocked down ITIH4 in macrophages, subsequently revealed that ITIH4 modulated anti-inflammatory responses via the NF-κB signaling pathway in macrophages. Moreover, macrophages with ITIH4 overexpression activated cAMP signaling pathway to enhance the viability and tight junction integrity of colonic epithelial cells.
conclusionThis study suggests that ITIH4 plays crucial roles in the inflammatory response of macrophages and may be an important molecule that regulates macrophage-epithelium interactions. Our findings shed new light into the molecular mechanism underlying macrophage drives intestinal inflammation and highlight ITIH4 as a therapeutic target for mitigating macrophages-induced intestinal damage.
Indexed as
Identifiers
41998424What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.